• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INFUSION Back to Search Results
Model Number 2426-0007
Device Problem Free or Unrestricted Flow (2945)
Patient Problem High Blood Pressure/ Hypertension (1908)
Event Date 05/29/2019
Event Type  Injury  
Manufacturer Narrative
Concomitant medical product: 250 ml baxter bag, lot y298372, exp aug 20, 0.9% sodium chloride injection.The customer¿s report of free-flow of 250ml of levophed within 2 minutes was confirmed and replicated.Testing of the set¿s roller clamp, pinch clamp, and pump segment safety clamp verified the clamps performed correctly.The lab pump module door was opened and closed multiple times to test the pump module safety clamp operation.It was observed that the clamp performed correctly and closed completely when the pump module door was opened.The set was then tested with the roller clamp open and the safety clamp 3/4 open (per the customer description), and the combination of clamp positions produced a free-flow event, confirming the customer's complaint.A measurement analysis of the set¿s silicone segment component was within specification.The root cause was identified as the combination of the set¿s roller clamp being in the open position and the pump segment safety clamp being 3/4 open.
 
Event Description
It was reported that levophed 250ml free-flowed within 2 minutes in the cticu.As the clinician was removing the iv tubing from the pump while still attached to the patient, the safety clamp was found to be 3/4 of the way open, and the roller clamp was not engaged prior to removal of the medication and tubing from the pump.The patient experienced an episode of hypertension, requiring the administration of labetalol.There was no report of lasting harm.The facility's unit clinician and staff used the set once it was discontinued from the patient to try to replicate the situation and they were unable to replicate the event.They tried inserting and removing over 20 times, and it did not fail.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INFUSION
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer (Section G)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
sylvia ventura
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key8739377
MDR Text Key149352864
Report Number9616066-2019-01677
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403227998
UDI-Public10885403227998
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 05/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/27/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2426-0007
Device Catalogue Number2426-0007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/13/2019
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
8100,8015, THERAPY DATE: (B)(6) 2019
Patient Outcome(s) Required Intervention;
-
-